Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Steroid saving effect of naproxen].

H Mathies

    Arzneimittel-Forschung
    |February 1, 1975
    PubMed
    Summary

    Naproxen demonstrated a prednisolone-sparing effect in rheumatoid arthritis patients, reducing steroid dosage by up to 10 mg daily. However, its efficacy compared to other antirheumatics varied in non-steroid-dependent patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Problems in quality assurance in physiotherapy of rheumatic diseases].

    Zeitschrift fur arztliche Fortbildung und Qualitatssicherung·2001
    Same author

    [Guideline for the joint swelling symptom--primary physician problem management and referral indications. German Society of Rheumatology "Quality Assurance" Committee].

    Zeitschrift fur Rheumatologie·2000
    Same author

    [Randomization in clinical studies--empirically founded or only a dogma?].

    Der Internist·1998
    Same author

    [Expanded anamnesis and psychodiagnostic classification of psychosomatic rheumatic patients. I: Anamnestic indications of psychosomatic correlations with manifestations of the locomotor system].

    Zeitschrift fur Rheumatologie·1993
    Same author

    [The therapy of pain in rheumatic joint-and spine diseases.].

    Schmerz (Berlin, Germany)·1990
    Same author

    [Expert assessment of psychosomatic disorders in rheumatology].

    Versicherungsmedizin·1989

    Area of Science:

    • Rheumatology
    • Pharmacology

    Background:

    • The Lansbury Index is inadequate for evaluating antirheumatic drug efficacy.
    • Prednisolone-sparing effect is a key metric for assessing therapeutic benefits.

    Purpose of the Study:

    • To investigate the prednisolone-sparing effect of naproxen in rheumatoid arthritis (RA) patients.
    • To compare naproxen with other antirheumatic agents in non-steroid-dependent RA patients.

    Main Methods:

    • Patients with RA received naproxen (750 mg/day) to assess its effect on reducing daily prednisolone dosage.
    • A separate study compared naproxen (500 mg/day) with indometacin, azapropazon, and nifluminic acid in patients not requiring steroids.
    • Evaluations included joint function and subjective changes.

    Main Results:

    • Naproxen (750 mg/day) showed a prednisolone-sparing effect of 5 mg/day in most RA patients.
    • Higher prednisolone doses (10 mg/day) saw savings of 7.5-10 mg with naproxen.
    • Naproxen's efficacy was variable when compared to other agents in non-steroid-dependent patients.
    • Gastrointestinal side effects were infrequent.

    Conclusions:

    • Naproxen exhibits a significant prednisolone-sparing effect in RA patients, indicating potential for reduced corticosteroid reliance.
    • Individual responses to naproxen's steroid-sparing effect vary.
    • Naproxen's comparative efficacy against other antirheumatics is not consistently superior in all patient groups.

    Related Experiment Videos